Eduardo Paredes is the head of Process Technology at a world leading CMO and has been in the Oligonucleotides field for over 10 years. His doctoral and post-doctoral work in Chemistry and Biochemistry from Carnegie Mellon University at the Center for Nucleic Acids Science and Technology and at the NIH/NCI respectively included modifying oligonucleotides for nanotechnological, biochemical and therapeutic applications. He has a background in organic synthetic chemistry, biochemistry, molecular biology, and virology. He currently oversees a group of ~50 chemists/scientists/engineers in new chemistry/raw materials onboarding, pre-clinical manufacture, process transfer and technology innovation to enable large-scale oligonucleotide manufacturing. Eduardo is originally from Mexico but has lived in the U.S. for ~20 years.